Paclitax 260 mg

Paclitax 260 is a medication used to treat various types of cancer, including breast cancer, ovarian cancer, and lung cancer. It is a chemotherapy medication that is used to treat cancer. Here are some key points about the product:

Composition:

Paclitax 260 contains Paclitaxel, a chemotherapy medication that is used to treat cancer.

Indications:

Paclitax 260 is indicated for the treatment of:

1. Breast cancer (metastatic)
2. Ovarian cancer (advanced)
3. Non-small cell lung cancer (NSCLC) (metastatic)
4. Gastric adenocarcinoma (metastatic)

Mechanism of Action:

Paclitaxel works by:

1. Interfering with the growth of microtubules in the cancer cells
2. Inhibiting the formation of the spindle apparatus, which is necessary for cell division
3. Causing cell death

Dosage and Administration: The recommended dosage of Paclitax 260 is:

• 260mg administered as a slow intravenous infusion over 30 minutes to 2 hours
• The dose may be adjusted based on the patient’s response to treatment and tolerability

Side Effects:

Common side effects of Paclitax 260 include:

1. Neutropenia (low white blood cell count)
2. Alopecia (hair loss)
3. Nausea and vomiting
4. Fatigue
5. Anemia (low red blood cell count)
6. Thrombocytopenia (low platelet count)
7. Increased risk of infections
8. Flu-like symptoms

Serious side effects can include:

1. Severe allergic reactions
2. Cardiac toxicity
3. Pulmonary toxicity
4. Hemorrhagic cystitis
5. Hepatotoxicity

Contraindications:

Paclitax 260 is contraindicated in patients with:

1. Hypersensitivity to Paclitaxel
2. Severe cardiac disease or cardiac failure
3. Severe liver disease or cirrhosis
4. Pregnancy or breastfeeding

Precautions:

1. Patients with a history of cardiac disease or cardiovascular risk factors should be closely monitored while receiving Paclitax 260.
2. Patients with a history of kidney disease or liver impairment should be closely monitored while receiving Paclitax 260.
3. Patients with a history of bleeding disorders should be closely monitored while receiving Paclitax 260.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of neutropenia, alopecia, or flu-like symptoms.
• Patients should be advised to report any changes in their appetite or weight loss.

Storage and Handling:

• Store at room temperature (20°C to 25°C) and protected from moisture.
• Do not freeze or expose to direct sunlight.
• Use within 24 hours of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.